Strikingly, the presence of VEGFR2/NRP1 trans‐complexes correlated with reduced vessel counts and reduced vessel branching, along with reduced tumor proliferation, in both the mouse cancer model and human PDAC (Figures 1, 4, and 5). Here, NRP1 is linked to cancer.